|
WO2020008320A1
|
|
Anti-xylan sulfate polyclonal antiserum and use thereof in elisa methods
|
|
IT201900003281A1
|
|
Process to prepare high purity {6 - [(diethylamino) methyl] naphthalen-2-yl} methyl [4- (hydroxycarbamoyl) phenyl] carbamate
|
|
CN107636021A
|
|
For the technique for preparing polysaccharide
|
|
EP3170836A1
|
|
Rp-hplc analysis of complex polypeptide mixtures
|
|
EP3147667A1
|
|
Analysis of the molecular weight distribution of complex polypeptide mixtures
|
|
EP3154993A1
|
|
Process for the purification of l-alpha-glycerophosphorylcholine
|
|
EP3083712A1
|
|
Process for the preparation of colesevelam
|
|
WO2015071335A1
|
|
Analytic methods for the determination of polysaccharides, especially glycosaminoglycans
|
|
WO2014202553A1
|
|
Lyophilized formulations of bendamustine hydrochloride
|
|
EP2948481A1
|
|
Method for the qualification of preparations of pentosan polysulfate, raw materials and production processes thereof
|
|
US2015232508A1
|
|
Bortezomib esters and formulations thereof
|
|
WO2013007694A1
|
|
Prodrug of an anti-inflammatory active ingredient
|
|
EP2481414A1
|
|
A process for the preparation of cross-linked polyallylamines or pharmaceutically acceptable salts thereof
|
|
CN102344452A
|
|
A novel process for the synthesis of pemetrexed disodium salt
|
|
WO2011154854A1
|
|
Process for the preparation of 2 -hydroxy- 4 -phenyl -3, 4 -dihydro-2h-chromen- 6 -yl -methanol and (r) - feso - deacyl
|
|
AU2010344330A1
|
|
Novel polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylamino methyl-2-naphtalenyl) ester
|
|
CN102206240A
|
|
Process for the synthesis of azacitidine and decitabine
|
|
EP2251317A1
|
|
Method for preparing fesoterodine and/or fesoterodine fumarate
|
|
EP2251318A1
|
|
Method for preparing fesoterodine fumarate
|
|
EP2196452A1
|
|
Process for obtaining fesoterodine fumarate in crystalline form I
|
